Sponsor Pipeline

Zhongmou Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07602127
Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy
Trial arms changed: 4 -> 3
Active Trials by Phase
Phase 1/2
1
Early Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07282457 Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy… Retinitis Pigmentosa (RP) Not Yet Recruiting
Early Phase 1
NCT06292650 Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients Retinitis Pigmentosa Recruiting
NCT07602127 Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy Geographic Atrophy Not Yet Recruiting
Not specified
NCT07085533 Natural History Study of Inherited Retinal Diseases Retinal Dystrophies Recruiting
Get alerts when Zhongmou Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free